There have been nearly $70 billion worth of deals in the pharmaceutical industry in 2008, almost double the value of last year. Eklavya Gupte investigates the reasons why there is so much activity and finds out how IP is driving the deals
Liu Shen & Associates, Beijing
Ernest Gutmann-Yves Plasseraud SAS, Lyon
Anand and Anand, New Delhi
May / June 2019
From trademarks to trade secrets: in-house tips on brand protection in China
Despite the well-known struggles in protecting trademarks and trade secrets in China, there are some tried-and-tested strategies to employ, as Karry Lai and Ellie Mertens hear from in-house counsel at a range of domestic and international companies
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2019 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International